Results 201 to 210 of about 5,581,867 (261)

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Cardiovascular-Kidney-Metabolic Syndrome and Life Expectancy in U.S. Adults. [PDF]

open access: yesJACC Adv
Ma N   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy